Free tool
Stocks listed on XETRA
We cover 45 companies listed on XETRA. The median market value in the group is $44.14B. Across the group, the median move over the past trading day is +0.11%. 70% of the 40 with a 200-day average trade above it. Price change over the past year runs from −20.4% to +59.5% across the middle 80 percent of the group, with a median of +7.9%.
Other lists in this group
Table
45 of 1,273 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| GIS.DE | Gilead Sciences, Inc. | 126.78 EUR | +7.51% | +23.41% | +33.64% |
| PFE.DE | Pfizer Inc. | 24.44 EUR | +10.09% | +18.44% | +22.96% |
| DAP.DE | Danaher Corporation | 184.45 EUR | +4.06% | −5.68% | +6.90% |
| VX1.DE | Vertex Pharmaceuticals Incorporated | 475.00 EUR | +10.21% | +23.55% | +41.64% |
| BRM.DE | Bristol-Myers Squibb Company | 58.02 EUR | +3.74% | +28.56% | +50.84% |
| IUI1.DE | Intuitive Surgical, Inc. | 318.75 EUR | +1.95% | −33.01% | −21.06% |
| SYK.DE | Stryker Corporation | 282.40 EUR | −8.40% | −4.46% | +34.90% |
| 2M6.DE | Medtronic plc | 78.54 EUR | +1.19% | −2.78% | +2.65% |
| SNW.DE | Sanofi | 78.75 EUR | −1.46% | +0.80% | −2.82% |
| GS71.DE | GSK plc | 22.35 EUR | −4.49% | +7.86% | +34.79% |
| A58.DE | Elevance Health, Inc. | 342.50 EUR | +2.03% | +13.81% | −19.30% |
| ESL.DE | EssilorLuxottica Société anonyme | 160.00 EUR | −2.85% | −38.15% | −39.11% |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | 717.90 EUR | +25.00% | +8.96% | −5.91% |
| CGN.DE | The Cigna Group | 237.40 EUR | −9.42% | +0.45% | −8.78% |
| MRK.DE | Merck KGaA | 139.35 EUR | −3.96% | +17.18% | +32.17% |
| BSX.DE | Boston Scientific Corporation | 42.30 EUR | +3.18% | −47.52% | −53.11% |
| 0QF.DE | Moderna, Inc. | 136.12 EUR | +181.04% | +417.17% | +550.51% |
| BAYN.DE | Bayer Aktiengesellschaft | 49.26 EUR | +3.29% | +30.00% | +76.91% |
| EWL.DE | Edwards Lifesciences Corporation | 77.24 EUR | +2.88% | +7.49% | +11.65% |
| BOX.DE | Becton, Dickinson and Company | 168.80 EUR | +23.08% | +2.38% | +1.73% |
| SHL.DE | Siemens Healthineers AG | 39.70 EUR | +5.75% | −7.90% | −14.18% |
| H6D0.DE | Haleon plc | 4.34 EUR | −3.02% | +2.63% | +5.39% |
| IX1.DE | IDEXX Laboratories, Inc. | 468.10 EUR | −2.09% | −17.59% | +17.97% |
| QTS.DE | IQVIA Holdings Inc. | 222.10 EUR | +19.34% | +15.23% | −4.04% |
| VEE.DE | Veeva Systems Inc. | 211.20 EUR | +15.44% | +12.55% | +13.43% |
| 2U3.DE | Alcon Inc. | 62.62 EUR | +2.25% | −4.76% | −7.70% |
| ILU.DE | Illumina, Inc. | 193.08 EUR | +13.91% | +69.73% | +129.80% |
| DC4.DE | DexCom, Inc. | 77.60 EUR | +16.52% | +37.44% | +21.06% |
| IDP.DE | Biogen Inc. | 190.12 EUR | +0.21% | +26.49% | +65.32% |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | 204.00 EUR | −19.59% | −40.19% | −10.21% |
| ZOE.DE | Zoetis Inc. | 65.74 EUR | −4.92% | −38.01% | −49.47% |
| FRE.DE | Fresenius SE & Co. KGaA | 45.85 EUR | +2.98% | −1.28% | +1.64% |
| 22UA.DE | BioNTech SE | 100.00 EUR | +23.08% | +21.29% | +14.09% |
| MTO.DE | Mettler-Toledo International Inc. | 1,222.00 EUR | +4.27% | +2.22% | +13.15% |
| PHI1.DE | Koninklijke Philips N.V. | 23.42 EUR | +2.76% | +5.23% | +3.22% |
| 56S1.DE | Sartorius Stedim Biotech S.A. | 194.20 EUR | +13.30% | −7.09% | +11.32% |
| GE9.DE | Genmab A/S | 294.20 EUR | +17.26% | +9.78% | −11.12% |
| SRT3.DE | Sartorius Aktiengesellschaft | 246.50 EUR | +9.26% | −0.18% | +25.88% |
| VIA.DE | Viatris Inc. | 14.27 EUR | −9.28% | +38.01% | +67.32% |
| QS51.DE | Straumann Holding AG | 98.00 EUR | −5.77% | −3.14% | −1.10% |
| CBHD.DE | Coloplast A/S | 61.54 EUR | +5.85% | −5.48% | +7.91% |
| SRT.DE | Sartorius Aktiengesellschaft | 195.00 EUR | +9.92% | +0.74% | +21.79% |
| ESF0.DE | Eurofins Scientific SE | 72.70 EUR | +7.58% | +17.51% | +12.65% |
| FME.DE | Fresenius Medical Care AG | 40.36 EUR | −7.39% | +4.49% | −2.61% |
| AFW.DE | Align Technology, Inc. | 143.00 EUR | −6.14% | +7.68% | −54.37% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.